Cresco Labs (CRLBF) Income from Continuing Operations (2020 - 2026)

Cresco Labs (CRLBF) reported Income from Continuing Operations of 11426000.0 for Q1 2026, down 14.72% on a YoY basis from 13398000.0 in Q1 2025, and up 113.39% quarter-over-quarter from 85341000.0 in Q4 2025.

Cresco Labs (CRLBF) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Cresco Labs has reported Income from Continuing Operations for 7 years, with the latest figure at 11426000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations fell 14.72% year-over-year to 11426000.0; the trailing twelve-month figure through Mar 2026 stood at 52770000.0 (down 382.13% YoY), and the FY2025 full-year result was 140044000.0, down 131.52% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 11426000.0, up from 85341000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 38980000.0 in Q2 2022, with the low at 133101000.0 in Q4 2022.
  • Historically, Income from Continuing Operations has averaged 8943176.47 across 5 years, with a median of 11426000.0 in 2026.
  • Annual changes were most pronounced in 2024 — Income from Continuing Operations soared 484.76% — and 2025, when it slumped 1604.87%.
  • Cresco Labs' Income from Continuing Operations stood at 133101000.0 in 2022, then surged by 115.6% to 20768000.0 in 2023, then slumped by 72.69% to 5671000.0 in 2024, then tumbled by 1604.87% to 85341000.0 in 2025, then jumped by 113.39% to 11426000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 11426000.0 (Q1 2026), 85341000.0 (Q4 2025), and 1766000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Cresco Labs - - 75.45 Mn 11.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.43 Mn
Dec 31, 2025 -85.34 Mn
Sep 30, 2025 1.77 Mn
Jun 30, 2025 19.38 Mn
Mar 31, 2025 13.40 Mn
Dec 31, 2024 5.67 Mn
Sep 30, 2024 30.34 Mn
Jun 30, 2024 -30.70 Mn
Mar 31, 2024 33.95 Mn
Dec 31, 2023 20.77 Mn
Sep 30, 2023 -124.94 Mn
Jun 30, 2023 -15.59 Mn
Mar 31, 2023 5.81 Mn
Dec 31, 2022 -133.10 Mn
Sep 30, 2022 34.22 Mn
Jun 30, 2022 38.98 Mn
Mar 31, 2022 21.94 Mn
Dec 31, 2021 35.15 Mn
Sep 30, 2021 -288.27 Mn
Jun 30, 2021 29.58 Mn